I pasted a couple of bits below but it doesn’t paste well. It’s best read from the link below where there’s loads more info. R.
Top of page 2:
Sufficient data have now accumulated to get a good overview of adverse 1https://yellowcard.mhra.gov.uk/the-yellow-card-scheme/
Evidence-Based ConsultancyMedicineLtdThedrug reactions(ADRs). Iwould, therefore,like to draw your attention to the high number of covid-19 vaccine-attributed deaths and ADRs that have been reported via the Yellow Card system between the 4thJanuary 2021 and the 26thMay 2021. In total,1,253deaths and 888,196ADRs (256,224individual reports) werereportedduring this period.
Bottom of Page 5 onwards:
Limitations of this rapid reportThis report is not comprehensive, and analysis of Yellow Card data is ongoing. The process of defining the search terms was iterative and we trust that it provides a basis for discussion amongclinicians and scientists. We have not compared the frequencies of ADRs between different vaccines; however, our impression is thatADRs were not limited to any particular vaccine brand (AstraZenenca, Pfizer and Moderna) or type (mRNA and DNA) currently used in the UK. UK ADR data mirror data reportedon the World Health Organization’s pharmacovigilance database
Evidence-Based ConsultancyMedicineLtdThe(www.Vigiaccess.org). On the latter, most reported ADRs to date (941,774 ADRs and 5,474 deaths) have occurred among individuals in the 18 to 44 years and 45 to 64 years of age categories (38% and 35%, respectively); the vast majority (72%) of reported ADRs have occurred among women. Unfortunately, we have been unable to examine the UK Yellow Card data accordingto age and gender due to lack of data availability.We are aware of the limitations of pharmacovigilance data and understand that information on reported Adverse Drug Reactions should not be interpreted as meaning that themedicine in question generally causes the observed effect or is unsafe to use. We are sharing this preliminary report due to the urgent need to communicate information that should lead to cessation of the vaccination roll out while a full investigation is conducted. According to the recent paper by Seneff and Nigh (1), potential acute and long-term pathologies include:•Pathogenic priming, multisystem inflammatory disease and autoimmunity•Allergic reactions and anaphylaxis•Antibody dependent enhancement•Activation of latent viral infections•Neurodegeneration and prion diseases•Emergence of novel variants of SARSCoV2•Integration ofthe spike protein gene into the human DNAThe nature and variety of ADRs reported to the Yellow Card System are consistent with the potential pathologies described in this paper and supported by otherrecent scientific papers onvaccine-induced harms, which are mediated through the vaccine spike proteinproduct(2,3). It is now apparent that these products in the blood streamare toxic to humans.An immediate halt to the vaccination programme is required whilst a full and independent safety analysis is undertaken to investigate the full extent of the harms, which the UK Yellow Card data suggest include thromboembolism, multisystem inflammatory disease, immune suppression, autoimmunity and anaphylaxis, as well asAntibody Dependent Enhancement (ADE). Due to the need for expedience, we have not detailed all ADRs in this preliminary report.The existing Yellow Card data covering just under a five-month period indicate that the extent of morbidity and mortality associated with the COVID-19 vaccines is unprecedented. Ageand gender specific data, as well as the time from vaccination,are requiredto further our analysis of these data and we have sent Freedom of Information Requests (FOIRs)to the MHRA in this regard.
Evidence-Based ConsultancyMedicineLtdTheInaddition, urgent independent expert evaluation and discussion is required to assess whether the novel vaccines may be causinggene mutations among recipients, as suggested by the occurrence of usually extremely rare geneticdisorders, such as Paroxysmal Extreme Pain Disorder(PEPD). In addition to the 11 cases of PEPD on the Yellow Card system, there are currently 12 reports of this extremely rare condition on the WHO’s Vigiaccess.orgdatabase and 10 on the European Medicines Agency’s (EUDRA) pharmacovigilance database. Are these ADRs occurring in babies of vaccinated pregnant women, or spuriously among vaccinated adults? This question needs urgent attention.As pharmacovigilance data are known to be substantiallyunder-reported, werecommend that the MHRA urgently publicises these ADR data and assists people with their ADR reporting, to facilitate full elucidation and clarification of the extent of the problem.The MHRA now has more than enough evidence on the Yellow Card system todeclare the COVID-19 vaccines unsafe for use in humans. Preparation should be made to scale up humanitarian efforts to assist those harmed by the COVID-19 vaccines and to anticipate and ameliorate medium to longer term effects. As the mechanism for harms from the vaccines appears to be similar to COVID-19itself, this includes engaging with numerous international doctors and scientists with expertise in successfully treating COVID-19.There are at least 3 urgent questions that need to be answered by the MHRA:1How many people have diedwithin 28 days of vaccination?2How many people have been hospitalised within 28 days of vaccination?3How many people have been disabled by the vaccination?EbMCSquared CiC remains at your service to assist with further analysis.Wekindly request full access to the Yellow Card database with immediate effect to enable a comprehensive, independent and accurate evaluation of the Yellow Card data, which will be undertaken in collaboration with clinical experts.Yours sincerely,Dr. Tess Lawrie(MBBCh, PhD)Director, Evidence-based Medicine Consultancy Ltd and EbMC Squared CiCBath, UK